Diagnostic study definition

Diagnostic study means a laboratory test, X-ray, ultrasound, or procedure used to identify a characteristic or distinguishing feature of a particular disease or condition.
Sample 1Sample 2
Diagnostic study means a laboratory test, X-ray, ultrasound, or other procedure used
Sample 1Sample 2
Diagnostic study means a laboratory test, X-ray, ultrasound, or procedure
Sample 1

Examples of Diagnostic study in a sentence

  • The Diagnostic study would identify and highlight the major problems and impediments of the cluster and a well – planned course of action / roadmap shall be prepared in order to support the cluster for self-sustaining growth.

  • As the Technical agency (ITCOT Consultancy and Services Limited) is involved in this cluster development process from the primary stage of preparation of Diagnostic study, it is observed that the lead SPV members are capable of undertaking the implementation of the project successfully in adherence to the project timelines.

  • Diagnostic study on the situation of the legal and regulatory framework governing the establishment of infrastructure and the management of its impacts on coastal and marine ecosystems in the Republic of Guinea-Bissau.

  • The Company and Business Unit level action plans were identified and implemented to move forward in the journey of business excellence.In order to enhance the customer satisfaction in Service, the Company constituted a Deep Dive Diagnostic study for After-Sales-Service process of Unitary Cooling Products business.

  • Diagnostic study of a cluster documents its strengths and weakenesses, operating environment and steps required for sustainable development with poverty reduction.

  • Diagnostic study of relationships between economic activity (e.g., production, employment) for industrial sectors in an area and the emissions estimated for those sectors, can also be to used to identify possible mismatches oroutliers.

  • As indicated in the Jobs Diagnostic study conducted in 2016, agriculture remains the largest employment sector, accounting for almost three-quarters of the total labor force.

  • DeliverableDescriptionTentative Time period6.1.Inception Report Diagnostic study of scope, adequacy and effectiveness of existing procedure relating to providing training to staff.1 Month6.2.Interim Reports Based on the above study, identify the training needs to be bridged.

  • Using NEC Commission Planning Documents and other information as appropriate, FRA identified and included on the NEC Project Inventory all projects that, based on FRA’s assessment of project information included in NEC Commission Planning Documents, are reasonably anticipated to be eligible under the FSP, and where the project sponsor indicated to FRA or the NEC Commission an intent to apply for funding under the FSP during the five-year BIL authorization period.

  • Diagnostic study on the power sector in Kazakhstan, Kyrgyz Republic, Tajikistan, and Uzbekistan, paving the way for the Regional Power Master Plan (RPMP), endorsed by the ESCC in May 2012.26 The RPMP estimates generation and transmission needs in Kazakhstan, Kyrgyz Republic, Tajikistan, and Uzbekistan at upward of $35 billion over the next 20 years; prioritizes identified investment opportunities; and recommends institutional measures necessary for implementation of these investments.


More Definitions of Diagnostic study

Diagnostic study means a study of a highway railroad grade crossing and any adjacent factors that will have an impact upon the operation at the grade crossing. This study shall be initiated by the department rail manager and shall be conducted by a diagnostic team constituted by the rail manager. Any reports submitted shall be stamped and signed by a registered engineer licensed in the state of New Mexico. A diagnostic study of a crossing shall be based on criteria and standards identified in the reference documents in subsection B of 18.14.4.8 NMAC.
Sample 1
Diagnostic study means any test used to help establish or exclude the presence of disease/injury in symptomatic persons. The test may help determine the diagnosis, screen for specific disease/injury, guide the management of an established disease/injury, and formulate a prognosis.
Sample 1
Diagnostic study means a laboratory test, X-ray, ultrasound, or procedure used to
Sample 1

Related to Diagnostic study

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Clinical Trial means any human clinical trial of a Product.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Therapeutic school means a residential group living facility:

  • Licensed Compound means [***].

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Diagnostic Service means an examination or procedure performed to obtain information regarding the medical condition of an outpatient.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.